| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 5.37K | $150K | $27.94 | Feb 22, 2024 | Direct |
| 9 METERS BIOPHARMA, INC. | Chief Financial Officer | Common stock | 41.1K | $9.35K | $0.23 | Apr 21, 2023 | Direct |
| SUPERNUS PHARMACEUTICALS, INC. | Director | Director Stock Option (Right to Buy) | 8.25K | Feb 22, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | Director |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Aug 17, 2023 | 1 | $0 | 4 | Aug 21, 2023 | Director |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Aug 17, 2023 | 0 | $0 | 3 | Aug 21, 2023 | Director |
| NMTR | 9 METERS BIOPHARMA, INC. | Apr 21, 2023 | 1 | -$11K | 4 | Apr 21, 2023 | Chief Financial Officer |
| NMTR | 9 METERS BIOPHARMA, INC. | Mar 27, 2023 | 1 | $0 | 4 | Mar 29, 2023 | Chief Financial Officer |
| NMTR | 9 METERS BIOPHARMA, INC. | Jan 18, 2022 | 1 | $0 | 4 | Jan 18, 2022 | Chief Financial Officer |
| NMTR | 9 METERS BIOPHARMA, INC. | Jan 17, 2022 | 0 | $0 | 3 | Jan 18, 2022 | Chief Financial Officer |